Amgen Inc. (AMGN) Management Presents at Cowen 41st Annual Healthcare Conference (Transcript)Seeking Alpha • 03/05/21
Amgen (AMGN) Down 5.5% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/04/21
FPRX Stock: The Huge Takeover News That Has Five Prime Therapeutics Shares Blasting HigherInvestorPlace • 03/04/21
Five Prime Therapeutics Stock Rockets On Amgen's $1.9 Billion TakeoverInvestors Business Daily • 03/04/21
Amgen to buy Five Prime Therapeutics in a deal valued at $1.9 billion to boost cancer treatment portfolioMarket Watch • 03/04/21
Tezepelumab Is The First Biologic To Significantly Reduce Exacerbations In Broad Population Of Patients With Severe, Uncontrolled AsthmaPRNewsWire • 02/26/21
Amgen Submits Supplemental New Drug Application for Otezla® (apremilast) for Adults with Mild-To-Moderate Plaque PsoriasisPRNewsWire • 02/22/21
FDA Grants Sotorasib Priority Review Designation For The Treatment Of Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung CancerPRNewsWire • 02/16/21
The $12 Billion Market That Has Biotech Stocks Hijacking The Immune SystemInvestors Business Daily • 02/12/21